Emma Ulker


Emma has over 15 years’ experience as an equity analyst mainly across the biotech, pharma and med tech sectors, including more than 10 years as an analyst at Edison Group where she covered a range of pan-European mid-cap stocks. More recently she has worked as a consultant, writing for Equity Development as well as Trinity Delta and Progressive Research. She started in the City on the equity sales desk at SG Securities, marketing UK equities to European fund managers. Emma focuses on providing clear, insightful and readable analysis.